カテゴリー： QYResearch, 世界, 医療/バイオ

世界のニコチン禁煙市場インサイト及び予測（チューインガム、パッチ、スプレー＆吸入器、その他）

◆英語タイトル：Global Nicotine Cessation Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09261 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：129 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、ニコチン禁煙のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にニコチン禁煙の世界市場のxxx％を占める「チューインガム」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ニコチン禁煙の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのニコチン禁煙市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ニコチン禁煙のグローバル主要企業には、GSK、Dr. Reddy's Laboratories、Cipla、Cigna、Chrono Therapeutics、Pfizer、Takeda、Achieve Life Sciences、McNeil AB、Ethismos、NJOY、Johnson & Johnson、JUUL Labs、Philip Morris International、VMR Products、Nicotek、Lorillard、Victory Electronic Cigarettes Corporation、Revolymer、Novartis International AG、Imperial Brands Plcなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ニコチン禁煙市場は、種類と用途によって区分されます。世界のニコチン禁煙市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
チューインガム、パッチ、スプレー＆吸入器、その他

【用途別セグメント】
病院、診療所、薬局、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ニコチン禁煙製品概要
- 種類別市場（チューインガム、パッチ、スプレー＆吸入器、その他）
- 用途別市場（病院、診療所、薬局、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のニコチン禁煙販売量予測2017-2028
- 世界のニコチン禁煙売上予測2017-2028
- ニコチン禁煙の地域別販売量
- ニコチン禁煙の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ニコチン禁煙販売量
- 主要メーカー別ニコチン禁煙売上
- 主要メーカー別ニコチン禁煙価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（チューインガム、パッチ、スプレー＆吸入器、その他）
- ニコチン禁煙の種類別販売量
- ニコチン禁煙の種類別売上
- ニコチン禁煙の種類別価格
・用途別市場規模（病院、診療所、薬局、その他）
- ニコチン禁煙の用途別販売量
- ニコチン禁煙の用途別売上
- ニコチン禁煙の用途別価格
・北米市場
- 北米のニコチン禁煙市場規模（種類別、用途別）
- 主要国別のニコチン禁煙市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのニコチン禁煙市場規模（種類別、用途別）
- 主要国別のニコチン禁煙市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のニコチン禁煙市場規模（種類別、用途別）
- 主要国別のニコチン禁煙市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のニコチン禁煙市場規模（種類別、用途別）
- 主要国別のニコチン禁煙市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのニコチン禁煙市場規模（種類別、用途別）
- 主要国別のニコチン禁煙市場規模（トルコ、サウジアラビア）
・企業情報
GSK、Dr. Reddy's Laboratories、Cipla、Cigna、Chrono Therapeutics、Pfizer、Takeda、Achieve Life Sciences、McNeil AB、Ethismos、NJOY、Johnson & Johnson、JUUL Labs、Philip Morris International、VMR Products、Nicotek、Lorillard、Victory Electronic Cigarettes Corporation、Revolymer、Novartis International AG、Imperial Brands Plc
・産業チェーン及び販売チャネル分析
- ニコチン禁煙の産業チェーン分析
- ニコチン禁煙の原材料
- ニコチン禁煙の生産プロセス
- ニコチン禁煙の販売及びマーケティング
- ニコチン禁煙の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ニコチン禁煙の産業動向
- ニコチン禁煙のマーケットドライバー
- ニコチン禁煙の課題
- ニコチン禁煙の阻害要因
・主な調査結果

Market Analysis and Insights: Global Nicotine Cessation Market
The global Nicotine Cessation market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Chewing Gum accounting for % of the Nicotine Cessation global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Nicotine Cessation market size is valued at US$ million in 2021, while the North America and Europe Nicotine Cessation are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nicotine Cessation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nicotine Cessation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nicotine Cessation market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nicotine Cessation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nicotine Cessation market.
Global Nicotine Cessation Scope and Market Size
Nicotine Cessation market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nicotine Cessation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Chewing Gum
Patches
Sprays and Inhalers
Others
Segment by Application
Hospital
Clinic
Pharmacy
Others
By Company
GSK
Dr. Reddy’s Laboratories
Cipla
Cigna
Chrono Therapeutics
Pfizer
Takeda
Achieve Life Sciences
McNeil AB
Ethismos
NJOY
Johnson & Johnson
JUUL Labs
Philip Morris International
VMR Products
Nicotek
Lorillard
Victory Electronic Cigarettes Corporation
Revolymer
Novartis International AG
Imperial Brands Plc
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nicotine Cessation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chewing Gum
1.2.3 Patches
1.2.4 Sprays and Inhalers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nicotine Cessation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nicotine Cessation Market Perspective (2017-2028)
2.2 Nicotine Cessation Growth Trends by Region
2.2.1 Nicotine Cessation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nicotine Cessation Historic Market Size by Region (2017-2022)
2.2.3 Nicotine Cessation Forecasted Market Size by Region (2023-2028)
2.3 Nicotine Cessation Market Dynamics
2.3.1 Nicotine Cessation Industry Trends
2.3.2 Nicotine Cessation Market Drivers
2.3.3 Nicotine Cessation Market Challenges
2.3.4 Nicotine Cessation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nicotine Cessation Players by Revenue
3.1.1 Global Top Nicotine Cessation Players by Revenue (2017-2022)
3.1.2 Global Nicotine Cessation Revenue Market Share by Players (2017-2022)
3.2 Global Nicotine Cessation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nicotine Cessation Revenue
3.4 Global Nicotine Cessation Market Concentration Ratio
3.4.1 Global Nicotine Cessation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nicotine Cessation Revenue in 2021
3.5 Nicotine Cessation Key Players Head office and Area Served
3.6 Key Players Nicotine Cessation Product Solution and Service
3.7 Date of Enter into Nicotine Cessation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nicotine Cessation Breakdown Data by Type
4.1 Global Nicotine Cessation Historic Market Size by Type (2017-2022)
4.2 Global Nicotine Cessation Forecasted Market Size by Type (2023-2028)
5 Nicotine Cessation Breakdown Data by Application
5.1 Global Nicotine Cessation Historic Market Size by Application (2017-2022)
5.2 Global Nicotine Cessation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nicotine Cessation Market Size (2017-2028)
6.2 North America Nicotine Cessation Market Size by Type
6.2.1 North America Nicotine Cessation Market Size by Type (2017-2022)
6.2.2 North America Nicotine Cessation Market Size by Type (2023-2028)
6.2.3 North America Nicotine Cessation Market Share by Type (2017-2028)
6.3 North America Nicotine Cessation Market Size by Application
6.3.1 North America Nicotine Cessation Market Size by Application (2017-2022)
6.3.2 North America Nicotine Cessation Market Size by Application (2023-2028)
6.3.3 North America Nicotine Cessation Market Share by Application (2017-2028)
6.4 North America Nicotine Cessation Market Size by Country
6.4.1 North America Nicotine Cessation Market Size by Country (2017-2022)
6.4.2 North America Nicotine Cessation Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nicotine Cessation Market Size (2017-2028)
7.2 Europe Nicotine Cessation Market Size by Type
7.2.1 Europe Nicotine Cessation Market Size by Type (2017-2022)
7.2.2 Europe Nicotine Cessation Market Size by Type (2023-2028)
7.2.3 Europe Nicotine Cessation Market Share by Type (2017-2028)
7.3 Europe Nicotine Cessation Market Size by Application
7.3.1 Europe Nicotine Cessation Market Size by Application (2017-2022)
7.3.2 Europe Nicotine Cessation Market Size by Application (2023-2028)
7.3.3 Europe Nicotine Cessation Market Share by Application (2017-2028)
7.4 Europe Nicotine Cessation Market Size by Country
7.4.1 Europe Nicotine Cessation Market Size by Country (2017-2022)
7.4.2 Europe Nicotine Cessation Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nicotine Cessation Market Size (2017-2028)
8.2 Asia-Pacific Nicotine Cessation Market Size by Type
8.2.1 Asia-Pacific Nicotine Cessation Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nicotine Cessation Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nicotine Cessation Market Share by Type (2017-2028)
8.3 Asia-Pacific Nicotine Cessation Market Size by Application
8.3.1 Asia-Pacific Nicotine Cessation Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nicotine Cessation Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nicotine Cessation Market Share by Application (2017-2028)
8.4 Asia-Pacific Nicotine Cessation Market Size by Region
8.4.1 Asia-Pacific Nicotine Cessation Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nicotine Cessation Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nicotine Cessation Market Size (2017-2028)
9.2 Latin America Nicotine Cessation Market Size by Type
9.2.1 Latin America Nicotine Cessation Market Size by Type (2017-2022)
9.2.2 Latin America Nicotine Cessation Market Size by Type (2023-2028)
9.2.3 Latin America Nicotine Cessation Market Share by Type (2017-2028)
9.3 Latin America Nicotine Cessation Market Size by Application
9.3.1 Latin America Nicotine Cessation Market Size by Application (2017-2022)
9.3.2 Latin America Nicotine Cessation Market Size by Application (2023-2028)
9.3.3 Latin America Nicotine Cessation Market Share by Application (2017-2028)
9.4 Latin America Nicotine Cessation Market Size by Country
9.4.1 Latin America Nicotine Cessation Market Size by Country (2017-2022)
9.4.2 Latin America Nicotine Cessation Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nicotine Cessation Market Size (2017-2028)
10.2 Middle East & Africa Nicotine Cessation Market Size by Type
10.2.1 Middle East & Africa Nicotine Cessation Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nicotine Cessation Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nicotine Cessation Market Share by Type (2017-2028)
10.3 Middle East & Africa Nicotine Cessation Market Size by Application
10.3.1 Middle East & Africa Nicotine Cessation Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nicotine Cessation Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nicotine Cessation Market Share by Application (2017-2028)
10.4 Middle East & Africa Nicotine Cessation Market Size by Country
10.4.1 Middle East & Africa Nicotine Cessation Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nicotine Cessation Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Nicotine Cessation Introduction
11.1.4 GSK Revenue in Nicotine Cessation Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 Dr. Reddy’s Laboratories
11.2.1 Dr. Reddy’s Laboratories Company Details
11.2.2 Dr. Reddy’s Laboratories Business Overview
11.2.3 Dr. Reddy’s Laboratories Nicotine Cessation Introduction
11.2.4 Dr. Reddy’s Laboratories Revenue in Nicotine Cessation Business (2017-2022)
11.2.5 Dr. Reddy’s Laboratories Recent Developments
11.3 Cipla
11.3.1 Cipla Company Details
11.3.2 Cipla Business Overview
11.3.3 Cipla Nicotine Cessation Introduction
11.3.4 Cipla Revenue in Nicotine Cessation Business (2017-2022)
11.3.5 Cipla Recent Developments
11.4 Cigna
11.4.1 Cigna Company Details
11.4.2 Cigna Business Overview
11.4.3 Cigna Nicotine Cessation Introduction
11.4.4 Cigna Revenue in Nicotine Cessation Business (2017-2022)
11.4.5 Cigna Recent Developments
11.5 Chrono Therapeutics
11.5.1 Chrono Therapeutics Company Details
11.5.2 Chrono Therapeutics Business Overview
11.5.3 Chrono Therapeutics Nicotine Cessation Introduction
11.5.4 Chrono Therapeutics Revenue in Nicotine Cessation Business (2017-2022)
11.5.5 Chrono Therapeutics Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Nicotine Cessation Introduction
11.6.4 Pfizer Revenue in Nicotine Cessation Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Nicotine Cessation Introduction
11.7.4 Takeda Revenue in Nicotine Cessation Business (2017-2022)
11.7.5 Takeda Recent Developments
11.8 Achieve Life Sciences
11.8.1 Achieve Life Sciences Company Details
11.8.2 Achieve Life Sciences Business Overview
11.8.3 Achieve Life Sciences Nicotine Cessation Introduction
11.8.4 Achieve Life Sciences Revenue in Nicotine Cessation Business (2017-2022)
11.8.5 Achieve Life Sciences Recent Developments
11.9 McNeil AB
11.9.1 McNeil AB Company Details
11.9.2 McNeil AB Business Overview
11.9.3 McNeil AB Nicotine Cessation Introduction
11.9.4 McNeil AB Revenue in Nicotine Cessation Business (2017-2022)
11.9.5 McNeil AB Recent Developments
11.10 Ethismos
11.10.1 Ethismos Company Details
11.10.2 Ethismos Business Overview
11.10.3 Ethismos Nicotine Cessation Introduction
11.10.4 Ethismos Revenue in Nicotine Cessation Business (2017-2022)
11.10.5 Ethismos Recent Developments
11.11 NJOY
11.11.1 NJOY Company Details
11.11.2 NJOY Business Overview
11.11.3 NJOY Nicotine Cessation Introduction
11.11.4 NJOY Revenue in Nicotine Cessation Business (2017-2022)
11.11.5 NJOY Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Nicotine Cessation Introduction
11.12.4 Johnson & Johnson Revenue in Nicotine Cessation Business (2017-2022)
11.12.5 Johnson & Johnson Recent Developments
11.13 JUUL Labs
11.13.1 JUUL Labs Company Details
11.13.2 JUUL Labs Business Overview
11.13.3 JUUL Labs Nicotine Cessation Introduction
11.13.4 JUUL Labs Revenue in Nicotine Cessation Business (2017-2022)
11.13.5 JUUL Labs Recent Developments
11.14 Philip Morris International
11.14.1 Philip Morris International Company Details
11.14.2 Philip Morris International Business Overview
11.14.3 Philip Morris International Nicotine Cessation Introduction
11.14.4 Philip Morris International Revenue in Nicotine Cessation Business (2017-2022)
11.14.5 Philip Morris International Recent Developments
11.15 VMR Products
11.15.1 VMR Products Company Details
11.15.2 VMR Products Business Overview
11.15.3 VMR Products Nicotine Cessation Introduction
11.15.4 VMR Products Revenue in Nicotine Cessation Business (2017-2022)
11.15.5 VMR Products Recent Developments
11.16 Nicotek
11.16.1 Nicotek Company Details
11.16.2 Nicotek Business Overview
11.16.3 Nicotek Nicotine Cessation Introduction
11.16.4 Nicotek Revenue in Nicotine Cessation Business (2017-2022)
11.16.5 Nicotek Recent Developments
11.17 Lorillard
11.17.1 Lorillard Company Details
11.17.2 Lorillard Business Overview
11.17.3 Lorillard Nicotine Cessation Introduction
11.17.4 Lorillard Revenue in Nicotine Cessation Business (2017-2022)
11.17.5 Lorillard Recent Developments
11.18 Victory Electronic Cigarettes Corporation
11.18.1 Victory Electronic Cigarettes Corporation Company Details
11.18.2 Victory Electronic Cigarettes Corporation Business Overview
11.18.3 Victory Electronic Cigarettes Corporation Nicotine Cessation Introduction
11.18.4 Victory Electronic Cigarettes Corporation Revenue in Nicotine Cessation Business (2017-2022)
11.18.5 Victory Electronic Cigarettes Corporation Recent Developments
11.19 Revolymer
11.19.1 Revolymer Company Details
11.19.2 Revolymer Business Overview
11.19.3 Revolymer Nicotine Cessation Introduction
11.19.4 Revolymer Revenue in Nicotine Cessation Business (2017-2022)
11.19.5 Revolymer Recent Developments
11.20 Novartis International AG
11.20.1 Novartis International AG Company Details
11.20.2 Novartis International AG Business Overview
11.20.3 Novartis International AG Nicotine Cessation Introduction
11.20.4 Novartis International AG Revenue in Nicotine Cessation Business (2017-2022)
11.20.5 Novartis International AG Recent Developments
11.21 Imperial Brands Plc
11.21.1 Imperial Brands Plc Company Details
11.21.2 Imperial Brands Plc Business Overview
11.21.3 Imperial Brands Plc Nicotine Cessation Introduction
11.21.4 Imperial Brands Plc Revenue in Nicotine Cessation Business (2017-2022)
11.21.5 Imperial Brands Plc Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のニコチン禁煙市場インサイト及び予測（チューインガム、パッチ、スプレー＆吸入器、その他）(Global Nicotine Cessation Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のニコチン禁煙市場インサイト及び予測（チューインガム、パッチ、スプレー＆吸入器、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp